VIR vs ZS · rev $238.9M vs rev $3.35B
Vir Biotechnology Inc (VIR) versus Zscaler Inc (ZS) — a side-by-side from cached financials, not a winner call.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Zscaler Inc (ZS) is a software - infrastructure company listed on US. It is led by Jagtar Singh Chaudhry.
Latest reported VIR revenue for 2026-06-30 was $238.9M. Net income was -$45.6M. VIR currently screens at market cap $1.45B.
Latest reported ZS revenue for 2026-07-31 was $3.35B. Net income was -$63.2M. Revenue was up 25.4% from 2025-07-31 to 2026-07-31. ZS currently screens at market cap $49.01B.
VIR currently screens at market cap $1.45B. ZS currently screens at market cap $49.01B.
Not investment advice. Open the VIR and ZS stock pages for the full models.
Not investment advice.